(Q46064068)

English

Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

author name string

Peter Qi

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Matvey Tsivian

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Michael R Abern

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Lionel L Bañez

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Ping Tang

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Judd W Moul

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Thomas J Polascik

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

publication date

12 July 2012

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Urologic Oncology

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

31

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

1527-1532

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Population screening for prostate cancer and emerging concepts for young men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

The relationship between preoperative prostate-specific antigen and biopsy Gleason sum in men undergoing radical retropubic prostatectomy: a novel assessment of traditional predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Lymphovascular invasion as a predictor of disease progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate ca

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.06.003

7 January 2021

Identifiers

10.1016/J.UROLONC.2012.06.003

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/22795501

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46064068&oldid=2089911448"